• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Xetra	102,200	01.10.24 12:09:13	+0,800	+0,79%	102,000	102,600	102,000	101,400
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	89,500	01.10.24 08:43:00	+2,500	+2,87%	89,500	91,000	89,500	87,000